Recently, decreased m6A RNA methylation level caused by METTL14 R298 mutation or decreased METTL3 expression has been reported to promote tumorigenicity and cell proliferation via activation of AKT signaling pathway in endometrial cancer 18. This evidence concerns the gene METTL14 and endometrial cancer.